Drugs to delay preterm birth are safe for global reduction in neonatal death
Women around the world should be able to access the best drug treatments that help to delay preterm births and improve outcomes for newborns, suggests new research.
Researchers from BHP founder-me…
Professor Peter Brocklehurst responds to the Women’s Health Strategy
The Chair of the Birmingham Health Partners Commission which led the Healthy Mum, Healthy Baby, Healthy Future report has welcomed the first ever Women’s Health Strategy for England to tackle the gen…
The BHP Starter Fellowship – Pip’s story
Pip Nicholson is a clinical lecturer in haematology at BHP founder-member the University of Birmingham, and completed his BHP Starter Fellowship between 2015 and 2016. His research is currently f…
BHP launches Seed Fund to invest in innovation
Today (20 June) Birmingham Health Partners officially launches its BHP Seed Fund – a new initiative which will kick-start innovation by providing researchers with up to £100,000 initial investment…
‘Cellular brake’ offers clue to autoimmune response during immunotherapy
A ‘cellular brake’ which could prevent lung cancer patients from developing a dangerous autoimmune response during treatment has been identified by scientists.
The finding, published in Nature Com…
The BHP Starter Fellowship – Shaun’s story
Shaun Thein is a Clinical Research Fellow in Respiratory Medicine at the University of Birmingham, and undertook his BHP Starter Fellowship between November 2020 and November 2021. He’s currently…